GATA3

GATA3
Dostupne strukture
PDB	Pretraga ortologa: PDBe RCSB
Spisak PDB ID kodova
	4HC7, 4HC9, 4HCA
Identifikatori
Aliasi	GATA3
Vanjski ID-jevi	OMIM: 131320 MGI: 95663 HomoloGene: 1550 GeneCards: GATA3
Lokacija gena (čovjek)
Hrom.	Hromosom 10 (čovjek)
Kraj	8,075,198 bp
Lokacija gena (miš)
Hrom.	Hromosom 2 (miš)
Kraj	9,894,845 bp
Obrazac RNK ekspresije
	; ; ; ;
	Više referentnih podataka o ekspresiji
Ontologija gena
Molekularna funkcija	• RNA polymerase II transcription regulatory region sequence-specific DNA binding; • HMG box domain binding; • chromatin binding; • vezivanje iona metala; • vezivanje sa DNK; • GO:0001158 cis-regulatory region sequence-specific DNA binding; • sequence-specific DNA binding; • GO:0001077, GO:0001212, GO:0001213, GO:0001211, GO:0001205 DNA-binding transcription activator activity, RNA polymerase II-specific; • GO:0001078, GO:0001214, GO:0001206 DNA-binding transcription repressor activity, RNA polymerase II-specific; • interleukin-2 receptor binding; • core promoter sequence-specific DNA binding; • GO:0000975 transcription cis-regulatory region binding; • protein dimerization activity; • E-box binding; • GO:0001948, GO:0016582 vezivanje za proteine; • vezivanje iona cinka; • transcription factor binding; • GO:0001105 transcription coactivator activity; • GO:0000980 RNA polymerase II cis-regulatory region sequence-specific DNA binding; • GO:0001131, GO:0001151, GO:0001130, GO:0001204 DNA-binding transcription factor activity; • GO:0001200, GO:0001133, GO:0001201 DNA-binding transcription factor activity, RNA polymerase II-specific; • GO:0001104 transcription coregulator activity;
Ćelijska komponenta	• jedro; • transcription regulator complex; • nukleoplazma;
Biološki proces	• negative regulation of cell population proliferation; • regulation of establishment of cell polarity; • ureteric bud formation; • negative regulation of cell cycle; • thymic T cell selection; • response to ethanol; • positive regulation of T cell differentiation; • erythrocyte differentiation; • inner ear morphogenesis; • cell maturation; • regulation of histone H3-K27 methylation; • cardiac right ventricle morphogenesis; • phosphatidylinositol 3-kinase signaling; • norepinephrine biosynthetic process; • ear development; • homeostasis of number of cells; • sympathetic nervous system development; • T-helper 2 cell differentiation; • regulation of cellular response to X-ray; • cell fate determination; • post-embryonic development; • cellular response to BMP stimulus; • mesonephros development; • neuron differentiation; • regulation of neuron apoptotic process; • GO:0072468 Transdukcija signala; • cellular response to cytokine stimulus; • cellular response to interleukin-4; • T cell receptor signaling pathway; • neuron migration; • positive regulation of interleukin-5 production; • regulation of CD4-positive, alpha-beta T cell differentiation; • parathyroid gland development; • negative regulation of DNA demethylation; • positive regulation of interleukin-4 production; • negative regulation of mammary gland epithelial cell proliferation; • GO:0044324, GO:0003256, GO:1901213, GO:0046019, GO:0046020, GO:1900094, GO:0061216, GO:0060994, GO:1902064, GO:0003258, GO:0072212 regulation of transcription by RNA polymerase II; • thymus development; • nervous system development; • otic vesicle development; • GO:0009373 regulation of transcription, DNA-templated; • positive regulation of T-helper 2 cell cytokine production; • regulation of nephron tubule epithelial cell differentiation; • positive regulation of thyroid hormone generation; • lymphocyte migration; • negative regulation of interleukin-2 production; • regulation of neuron projection development; • uterus development; • axon guidance; • mesenchymal to epithelial transition; • negative regulation of cell proliferation involved in mesonephros development; • aortic valve morphogenesis; • cellular response to tumor necrosis factor; • negative regulation of fat cell differentiation; • anatomical structure morphogenesis; • cellular response to interferon-alpha; • GO:0045996 negative regulation of transcription, DNA-templated; • T cell differentiation; • response to virus; • negative regulation of endothelial cell apoptotic process; • Urođeni imunski sistem; • canonical Wnt signaling pathway involved in metanephric kidney development; • positive regulation of transcription regulatory region DNA binding; • positive regulation of endothelial cell migration; • positive regulation of interleukin-13 production; • in utero embryonic development; • negative regulation of interferon-gamma production; • humoral immune response; • developmental growth; • Nefrogeneza; • positive regulation of ureteric bud formation; • GO:1901313 positive regulation of gene expression; • mast cell differentiation; • positive regulation of histone H3-K9 acetylation; • positive regulation of cell differentiation; • GO:1901227 negative regulation of transcription by RNA polymerase II; • male gonad development; • nephric duct morphogenesis; • ventricular septum development; • GO:0032737 positive regulation of cytokine production; • lens development in camera-type eye; • negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation; • transcription, DNA-templated; • negative regulation of gene expression; • parathyroid hormone secretion; • nephric duct formation; • immune system process; • negative regulation of inflammatory response; • pharyngeal system development; • embryonic organ development; • response to estrogen; • Koagulacija (krv); • negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation; • positive regulation of signal transduction; • ureter maturation; • positive regulation of histone H3-K14 acetylation; • GO:0060469, GO:0009371 positive regulation of transcription, DNA-templated; • response to gamma radiation; • GO:0000767 cell morphogenesis; • embryonic hemopoiesis; • GO:0003257, GO:0010735, GO:1901228, GO:1900622, GO:1904488 positive regulation of transcription by RNA polymerase II; • negative regulation of cell motility; • pro-T cell differentiation; • TOR signaling; • type IV hypersensitivity; • defense response; • regulation of histone H3-K4 methylation; • renal system development; • positive regulation of protein kinase B signaling; • cell activation; • chromatin remodeling; • T cell differentiation in thymus; • cochlea development; • transcription by RNA polymerase II; • protein deubiquitination; • anatomical structure formation involved in morphogenesis; • regulation of hematopoietic stem cell differentiation; • cytokine-mediated signaling pathway; • heart development; • animal organ morphogenesis; • tissue development; • cell development; • digestive tract development; • immune system development; • regulation of epithelial cell differentiation; • ureter morphogenesis;
	Izvori:Amigo / QuickGO
Ortolozi
	2625
	14462
	ENSG00000107485
	ENSMUSG00000015619
	P23771
	P23772
	NM_001002295; NM_002051
	NM_008091; NM_001355110; NM_001355111; NM_001355112
	NP_001002295; NP_002042
	NP_032117; NP_001342039; NP_001342040; NP_001342041
	Wikipodaci
Pogledaj/uredi – čovjek	Pogledaj/uredi – miš

GATA3 je transkripcijski faktor koji je kod ljudi kodiran genom GATA3. Studije na životinjskim modelima i ljudima pokazuju da kontrolira ekspresiju širokog spektra biološki i klinički važnih gena.^[5]^[6]^[7]

Transkripcijski faktor GATA3 kritičan je za embrionski razvoj različitih tkiva, kao i za upalnu i humoralnu imunsku reakciju i pravilno funkcioniranje endotela krvnih sudova. GATA3 ima centralnu ulogu u alergijama i imunosti protiv infekcija glistama.^[8]^[9] Haploinsuficiencija GATA3 (tj. gubitak jednog ili dva naslijeđena gena GATA3) rezultira kongenitalnim poremećajem koji se naziva Barakatov sindrom.^[10]^[11]^[12]

Sadašnja klinička i laboratorijska istraživanja usredotočena su na utvrđivanje prednosti izravnog ili neizravnog blokiranja djelovanja GATA3 kod upalnih i alergijskih bolesti, ko što je astma. Također se predlaže da bude klinički važan marker za različite tipove raka, posebno one raka dojke. Međutim, ako postoji, uloga GATA3 u razvoju ovih karcinoma se proučava i ostaje nejasna.^[13]

Aminokiselinska sekvenca

Dužina polipeptidnog lanca je 443 aminokiseline, а molekulska težina 47 916 Da.^[14]

10	20	30	40	50
MEVTADQPRW	VSHHHPAVLN	GQHPDTHHPG	LSHSYMDAAQ	YPLPEEVDVL
FNIDGQGNHV	PPYYGNSVRA	TVQRYPPTHH	GSQVCRPPLL	HGSLPWLDGG
KALGSHHTAS	PWNLSPFSKT	SIHHGSPGPL	SVYPPASSSS	LSGGHASPHL
FTFPPTPPKD	VSPDPSLSTP	GSAGSARQDE	KECLKYQVPL	PDSMKLESSH
SRGSMTALGG	ASSSTHHPIT	TYPPYVPEYS	SGLFPPSSLL	GGSPTGFGCK
SRPKARSSTG	RECVNCGATS	TPLWRRDGTG	HYLCNACGLY	HKMNGQNRPL
IKPKRRLSAA	RRAGTSCANC	QTTTTTLWRR	NANGDPVCNA	CGLYYKLHNI
NRPLTMKKEG	IQTRNRKMSS	KSKKCKKVHD	SLEDFPKNSS	FNPAALSRHM
SSLSHISPFS	HSSHMLTTPT	PMHPPSSLSF	GPHHPSSMVT	AMG

C: Cistein

D: Asparaginska kiselina

E: Glutaminska kiselina

F: Fenilalanin

G: Glicin

H: Histidin

I: Izoleucin

K: Lizin

L: Leucin

M: Metionin

N: Asparagin

P: Prolin

Q: Glutamin

R: Arginin

S: Serin

T: Treonin

V: Valin

W: Triptofan

Y: Tirozin

Gen

Gen GATA3 nalazi se blizu kraja kratkog kraka hromosoma 10, na poziciji p14. Sastoji se od osam egzona i kodira dvije varijante; varijanta 1 i GATA3, varijanta 2.^[15] Ekspresija GATA3 može biti djelimično reguliranaregulated in part or putem antisens RNK, GATA3-AS1, čiji geni su locirani u blizini genaGATA3, na kratkom kraku hromosoma 10, pozicija p14.^[16] Različiti tipovi mutacija uključujući tačkaste mutacije kao i male i velike delecijske mutacije uzrokuju autosomno dominantni genetički poremećaj , Barakatov sindrom (koji se naziva i hipoparatiroidizam, gluhoća i sindrom bubrežne displazije). Lokus GATA3 graniči s drugim kritičnim mjestima na hromosomu 10, posebno lokacijom koja se nalazi na 10p14-p13. Mutacije na ovom mjestu uzrokuju urođeni poremećaj DiGeorgeov sindrom/kompleks 2 velokardiofacijalnog sindroma (ili DiGeorgeov sindrom 2).^[17] Velikoskalirane delecije u GATA3 mogu se proširiti na područje DiGeorge sindroma 2 i na taj način uzrokovati složeni sindrom sa obilježjima Barakatovog sindroma u kombinaciji s nekim od onih iz DiGeorgeovog sindroma 2.^[12]^[18] Nokaut oba gena GATA3 kod miševa je fatalan: ove životinje umiru u embrionskim danima 11 i 12, zbog unutrašnjeg krvarenja. Također pokazuju velike deformitete u mozgu i kičmi, kao i aberacije u jetrenoj hematopoezi fetusa.^[19]

Protein

GATA3 varijanta 1 je linearni protein koji se sastoji od 444 aminokiseline. Proteinska GATA3 varijanta 2 je identično strukturirana izoforma, ali je kraća za jednu aminokiselinu od GATA3 varijante 1. Razlike, ako ih ima, u funkcijama ove dvije varijante nisu prijavljene.^[20] varijanta 2, iRNK. Što se tiče najbolje proučene varijante, varijanta 1, ali vjerovatno i varijanta 2 , jedan od strukturnih motiva cinkovog prsta, ZNF2, nalazi se na C-kraju proteina i veže se za specifične promotore gena. Sekvence DNK reguliraju ekspresiju gena koje kontroliraju ovi promotori. Drugi cinkov prst, ZNF1, nalazi se na proteinskom N-terminalu i stupa u interakciju s različitim jedarnim faktorima, uključujući protein cinkovog prsta 1 (tj. ZFPM1, koji se također naziva šaperonom GATA1 (tj. FOG-1) i ZFPM2 (tj. FOG-2), koji moduliraju djelovanje GATA3 gena za stimulaciju.^[21]

Patofiziologija

Transkripcijski faktor GATA3 regulira ekspresiju gena uključenih u razvoj različitih tkiva, kao i gena uključenih u fiziološke kao i patološke humoralne upalne i alergijske reakcije.^[10]^[12]

Funkcija

GATA3 pripada porodici GATA faktora transkripcije. Studije delecije gena na miševima. pokazuju da je Gata3 (gen miša ekvivalentan GATA3) kritičan za embrionski razvoj i/ili funkciju različitih tipova ćelija (npr. mast ćelije, ćelije nervog grebena, limfociti) i tkiva više organa (npr. bubreg, jetra, mozak, kičmena moždina, mliječne žlijezde).^[11] Studije na ljudima implicira GATA3 na sljedeće:

GATA3 je potreban za razvoj paratiroidne žlijezde, senzornih komponenti slušnog sistema i bubrega kod životinja i ljudi.^[12] Može se takođe doprinose razvoju vagine i materice kod ljudi.^[22]
Kod ljudi, GATA3 je potreban za razvoj i/ili funkciju urođenih limfoidnih ćelija (ILC), posebno ILC grupe 2, kao i za razvoj T pomoćnih ćelija, (Th ćelije), posebno Th2 ćelija. ILC grupe 2 i Th2 ćelije, a time i GATA3, kritični su za razvoj alergijskih i humoralnoimunskog odgovora kod ljudi. Uporedne studije na životinjama ukazuju na da GATA3 utiče na razvoj limfocita koji posreduju u alergijskoj i humoralnoi imunosti, kao i u alergijskim i humoralnim imunskim odgovorima.^[22]^[23]
GATA3 podstiče lučenje IL-4, IL-5 i IL-13 iz Th2 ćelija kod ljudi i ima slična djelovanja na slične mišje limfocite. Sva tri ova interleukina služe za podsticanje alergijske reakcije,^[24]
GATA3 inducira sazrijevanje prekursornih epitelneih ćelija dojke i održava ih u zrelom stanju kod miševa i vjerovatno ljudi.^[25]^[26]
Kod miševa, GATA3 je odgovoran za normalan razvoj različitih tkiva, uključujući kožu, mastocite, timus i nervni sistem.^[22]^[27]

Klinički značaj

Mutacije

Inaktiviranje mutacija u jednom od dva roditeljska gena GATA3 uzrokuje kongenitalni poremećaj hipoparatiroidizam sa senzorinervnom gluhoćom i bubrežnim malformacijama, tj. Barakatovim sindromom. Ovaj rijetki sindrom može se pojaviti u porodicama ili kao nova mutacija kod osoba iz porodice bez historije poremećaja. Mutacije u GATA3 uzrokuju različite stupnjeve hipoparatiroidizma, gluhoće i urođene mahane bolesti bubrega zbog

Individualnih razlika u penetraciji mutacije,
sporadična, i još uvijek nerazjašnjena, povezanost s malformacijama maternice i vagine, i *mutacije koje se protežu izvan gena GATA3 u hromosomska područja gdje su mutacije odgovorne za razvoj drugih tipova abnormalnosti koje su karakteristike DeGeorgeovog sindroma 2. Barakatov sindrom nastaje zbog haploinsuficijencija u nivoima GATA3, odnosno nivoa transkripcijskih faktora koji su nedovoljni za normalan razvoj pomenutih tkiva tokom embriogeneze.^[11]^[12]^[18]

Alergija

Studije na miševima pokazuju da inhibiranje ekspresije GATA3 metodima antisens RNK potiskuje alergijsku upalu. Protein je nadeksprimiran u zahvaćenim tkivima osoba s različitim oblicima alergija, uključujući astmu, rinitis, nosne polipe i atopijski ekcem. To sugerira da bi on mogao imati ulogu u podsticanju ovih poremećaja.^[28] U fazi IIA kliničkih ispitivanja studija osoba koji pate od astme uzrokovane alergenima, inhalacija dezoksiribozimom ST010, koja specifično inaktivira GATA3 iRNK, smanjena je za 28 dana rani i kasni imunski odgovor pluća na inhalacijski alergen. Smatra se da je klinička korist inhibicije GATA3 u ovom poremećaju posljedica ometanja funkcije ILC-a Grupe 2 i Th2-ćelija, naprimjer, smanjenjem proizvodnje IL-4, IL-13, a posebno IL-5. Smatra se da smanjenje ovih eozinofilno-stimulirajućih interleukina, smanjuje sposobnost ovih ćelija da podstiču alergijsku reaktivnost i reakcije.^[10]^[29] Iz sličnih razloga, liječenje bi se također moglo pokazati klinički korisnim za liječenje drugih alergijskih poremećaja.^[28]

Tumori

Tumori dojke

Razvoj

GATA3 je jedan od tri mutirana gena u > 10% slučajeva raka dojke (Cancer Genome Atlas).^[30] Studije na miševima pokazuju da je gen kritičan za normalan razvoj tkiva dojke i izravno regulira diferencijaciju lumenskih ćelija (tj. ćelijaa koje oblažu mliječne kanale) u eksperimentalno induciranom karcinomu dojke.^[19]^[31] Analize ljudskog tkiva raka dojke ukazuju da je GATA3 potreban za specifični tip raka dojke niskog rizika (tj. lumenski A), sastavni je dio ekspresije receptora estrogena alfa i (kod receptora estrogena negativnih/pozitivnih karcinoma receptora androgena) signalizacija androgenih receptora.^[32]^[33]^[34] Ove studije sugeriraju da je "GATA3" uključen u razvoj barem određenih tipova raka dojke kod ljudi. Međutim, postoji neslaganje oko toga, a neke studije sugeriraju da ekspresija "GATA3" djeluje tako da inhibira, a druge studije sugeriraju da djeluje na podsticanje razvoja, rasta i/ili širenja ovog raka. Potrebne su daljnje studije kako bi se razjasnila uloga, ako postoji, GATA3 u razvoju raka dojke.^[19]

Marker

Imuocitokemijska analiza proteina GATA3 u ćelijama dojke vrijedan je marker za dijagnosticiranje primarnog karcinoma dojke, testiran je kao pozitivan u do 94% slučajeva. Posebno je vrijedan za karcinom dojke pozitivan na estrogene receptore, ali je manje osjetljiv (43,5-66% povišen), iako je još uvijek vrijedniji od mnogih drugih markera za dijagnosticiranje trostruko negativnog raka dojke. Ova analiza se naširoko koristi kao klinički vrijedan marker raka dojke.^[35]^[36]

Ostali tipovi tumora

Slično tumorima dojke, uloga GATA3 u genezi drugih tipova tumora nije jasna, ali otkrivanje proizvoda njegovog transkripcijskog faktora može biti dijagnostički korisno. Imuocitohemijska analiza proteina GATA3 smatra se vrijednim markerom za određene vrste raka mokraćnog mjehura i raka mokraćovoda, kao i za tumore paratiroidne žlijezde (kancerogene ili benigne). Za pojedinačne serije izvještaji sugeriraju da bi ova analiza mogla biti od koristi i za dijagnosticiranje tumora pljuvačnih žlijezda, karcinom pljuvačnih kanala, analognog sekretornog karcinoma dojke, benignih tuomra jajnika Brenerovih tumora , benignih Walthardovih ćelija i paraganglioma.^[13]^[37]

Interakcije

Pokazalo se da GATA3 stupa u interakciju sa sljedećim regulatorima transkripcijskih faktora: ZFPM1 i ZFPM2;^[21] LMO1;^[38]^[39] i FOXA1.^[40] Ovi regulatori mogu promovirati ili inhibirati GATA3 u podsticanju ekspresije njegovih ciljnih gena.

Također pogledajte

Transkripcijski faktor GATA

Reference

^ ^a ^b ^c GRCh38: Ensembl release 89: ENSG00000107485 - Ensembl, maj 2017
^ ^a ^b ^c GRCm38: Ensembl release 89: ENSMUSG00000015619 - Ensembl, maj 2017
^ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
^ Joulin V, Bories D, Eléouet JF, Labastie MC, Chrétien S, Mattéi MG, Roméo PH (Jul 1991). "A T-cell specific TCR delta DNA binding protein is a member of the human GATA family". The EMBO Journal. 10 (7): 1809–16. doi:10.1002/j.1460-2075.1991.tb07706.x. PMC 452855. PMID 2050118.
^ Yamashita M, Ukai-Tadenuma M, Miyamoto T, Sugaya K, Hosokawa H, Hasegawa A, Kimura M, Taniguchi M, DeGregori J, Nakayama T (Jun 2004). "Essential role of GATA3 for the maintenance of type 2 helper T (Th2) cytokine production and chromatin remodeling at the Th2 cytokine gene loci". The Journal of Biological Chemistry. 279 (26): 26983–90. doi:10.1074/jbc.M403688200. PMID 15087456.
^ "Entrez Gene: GATA3 GATA binding protein 3".
^ Zheng, Wei-ping; Flavell, Richard A (maj 1997). "The Transcription Factor GATA-3 Is Necessary and Sufficient for Th2 Cytokine Gene Expression in CD4 T Cells". Cell. 89 (4): 587–596. doi:10.1016/s0092-8674(00)80240-8. PMID 9160750. S2CID 18342599.
^ Zheng, WP; Flavell, RA (1. 6. 2016). "Pillars Article: The Transcription Factor GATA-3 Is Necessary and Sufficient for Th2 Cytokine Gene Expression in CD4 T Cells. Cell. 1997. 89: 587-596". Journal of Immunology. 196 (11): 4426–35. PMID 27207805.
^ ^a ^b ^c Barnes PJ (april 2018). "Targeting cytokines to treat asthma and chronic obstructive pulmonary disease". Nature Reviews. Immunology. 18 (7): 454–466. doi:10.1038/s41577-018-0006-6. PMID 29626211. S2CID 4647119.
^ ^a ^b ^c "OMIM Entry - * 131320 - GATA-BINDING PROTEIN 3; GATA3". omim.org.
^ ^a ^b ^c ^d ^e Belge H, Dahan K, Cambier JF, Benoit V, Morelle J, Bloch J, Vanhille P, Pirson Y, Demoulin N (maj 2017). "Clinical and mutational spectrum of hypoparathyroidism, deafness and renal dysplasia syndrome". Nephrology, Dialysis, Transplantation. 32 (5): 830–837. doi:10.1093/ndt/gfw271. PMID 27387476.
^ ^a ^b Ordóñez NG (septembar 2013). "Value of GATA3 immunostaining in tumor diagnosis: a review". Advances in Anatomic Pathology. 20 (5): 352–60. doi:10.1097/PAP.0b013e3182a28a68. PMID 23939152. S2CID 8874053.
^ "UniProt, P23771". Pristupljeno 2. 9. 2021.
^ "Homo sapiens GATA binding protein 3 (GATA3), RefSeqGene on chromosome - Nucleotide - NCBI". www.ncbi.nlm.nih.gov. 21. 5. 2019.
^ "GATA3-AS1 GATA3 antisense RNA 1 [Homo sapiens (human)] - Gene - NCBI".
^ "DiGeorge syndrome/velocardiofacial syndrome complex 2 - Conditions - GTR - NCBI". www.ncbi.nlm.nih.gov.
^ ^a ^b Lindstrand A, Malmgren H, Verri A, Benetti E, Eriksson M, Nordgren A, Anderlid BM, Golovleva I, Schoumans J, Blennow E (maj 2010). "Molecular and clinical characterization of patients with overlapping 10p deletions". American Journal of Medical Genetics. Part A. 152A (5): 1233–43. doi:10.1002/ajmg.a.33366. PMID 20425828. S2CID 22213304.
^ ^a ^b ^c Du F, Yuan P, Wang T, Zhao J, Zhao Z, Luo Y, Xu B (novembar 2015). "The Significance and Therapeutic Potential of GATA3 Expression and Mutation in Breast Cancer: A Systematic Review". Medicinal Research Reviews. 35 (6): 1300–15. doi:10.1002/med.21362. PMID 26313026. S2CID 11668034.
^ "Homo sapiens GATA binding protein 3 (GATA3), transcript variant 2, mRN - Nucleotide - NCBI". www.ncbi.nlm.nih.gov. 19. 5. 2019.
^ ^a ^b "trans-acting T-cell-specific transcription factor GATA-3 isoform 1 [Ho - Protein - NCBI". www.ncbi.nlm.nih.gov.
^ ^a ^b ^c "OMIM Entry - * 131320 - GATA-BINDING PROTEIN 3; GATA3".
^ Zhu J (2017). "GATA3 Regulates the Development and Functions of Innate Lymphoid Cell Subsets at Multiple Stages". Frontiers in Immunology. 8: 1571. doi:10.3389/fimmu.2017.01571. PMC 5694433. PMID 29184556.
^ Yagi R, Zhu J, Paul WE (Jul 2011). "An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiation Z". International Immunology. 23 (7): 415–20. doi:10.1093/intimm/dxr029. PMC 3123974. PMID 21632975.
^ Kouros-Mehr H, Slorach EM, Sternlicht MD, Werb Z (Dec 2006). "GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland". Cell. 127 (5): 1041–55. doi:10.1016/j.cell.2006.09.048. PMC 2646406. PMID 17129787.
^ Asch-Kendrick R, Cimino-Mathews A (februar 2016). "The role of GATA3 in breast carcinomas: a review". Human Pathology. 48: 37–47. doi:10.1016/j.humpath.2015.09.035. PMID 26772397.
^ Ho IC, Pai SY (februar 2007). "GATA-3 - not just for Th2 cells anymore". Cellular & Molecular Immunology. 4 (1): 15–29. PMID 17349208.
^ ^a ^b Bachert C, Zhang L, Gevaert P (decembar 2015). "Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis". The Journal of Allergy and Clinical Immunology. 136 (6): 1431–1440. doi:10.1016/j.jaci.2015.10.010. PMID 26654192.
^ Garn H, Renz H (januar 2017). "GATA-3-specific DNAzyme - A novel approach for stratified asthma therapy". European Journal of Immunology. 47 (1): 22–30. doi:10.1002/eji.201646450. PMID 27910098.
^ Koboldt DC, Fulton RS, McLellan MD (Oct 2012). "Comprehensive molecular portraits of human breast tumours". Nature. 490 (7418): 61–70. Bibcode:2012Natur.490...61T. doi:10.1038/nature11412. PMC 3465532. PMID 23000897.
^ Kouros-Mehr H, Bechis SK, Slorach EM, Littlepage LE, Egeblad M, Ewald AJ, Pai SY, Ho IC, Werb Z (Feb 2008). "GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model". Cancer Cell. 13 (2): 141–52. doi:10.1016/j.ccr.2008.01.011. PMC 2262951. PMID 18242514.
^ Wilson BJ, Giguère V (2008). "Meta-analysis of human cancer microarrays reveals GATA3 is integral to the estrogen receptor alpha pathway". Molecular Cancer. 7: 49. doi:10.1186/1476-4598-7-49. PMC 2430971. PMID 18533032.
^ Dydensborg AB, Rose AA, Wilson BJ, Grote D, Paquet M, Giguère V, Siegel PM, Bouchard M (Jul 2009). "GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis". Oncogene. 28 (29): 2634–42. doi:10.1038/onc.2009.126. PMID 19483726.
^ Sanga S, Broom BM, Cristini V, Edgerton ME (2009). "Gene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and implies interactions with ErbB family". BMC Medical Genomics. 2: 59. doi:10.1186/1755-8794-2-59. PMC 2753593. PMID 19747394.
^ Liu H, Shi J, Wilkerson ML, Lin F (juli 2012). "Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas". American Journal of Clinical Pathology. 138 (1): 57–64. doi:10.1309/AJCP5UAFMSA9ZQBZ. PMID 22706858.
^ Peng Y, Butt YM, Chen B, Zhang X, Tang P (august 2017). "Update on Immunohistochemical Analysis in Breast Lesions". Archives of Pathology & Laboratory Medicine. 141 (8): 1033–1051. doi:10.5858/arpa.2016-0482-RA. PMID 28574279.
^ Inamura K (april 2018). "Bladder Cancer: New Insights into Its Molecular Pathology". Cancers. 10 (4): 100. doi:10.3390/cancers10040100. PMC 5923355. PMID 29614760.
^ Ono Y, Fukuhara N, Yoshie O (Dec 1998). "TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3". Molecular and Cellular Biology. 18 (12): 6939–50. doi:10.1128/MCB.18.12.6939. PMC 109277. PMID 9819382.
^ Ono Y, Fukuhara N, Yoshie O (Feb 1997). "Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL". The Journal of Biological Chemistry. 272 (7): 4576–81. doi:10.1074/jbc.272.7.4576. PMID 9020185.
^ Albergaria A, Paredes J, Sousa B, Milanezi F, Carneiro V, Bastos J, Costa S, Vieira D, Lopes N, Lam EW, Lunet N, Schmitt F (2009). "Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours". Breast Cancer Research. 11 (3): R40. doi:10.1186/bcr2327. PMC 2716509. PMID 19549328.

Dopunska literatura

Naylor MJ, Ormandy CJ (2007). "Gata-3 and mammary cell fate". Breast Cancer Research. 9 (2): 302. doi:10.1186/bcr1661. PMC 1868924. PMID 17381824.
Ho IC, Vorhees P, Marin N, Oakley BK, Tsai SF, Orkin SH, Leiden JM (maj 1991). "Human GATA-3: a lineage-restricted transcription factor that regulates the expression of the T cell receptor alpha gene". The EMBO Journal. 10 (5): 1187–92. doi:10.1002/j.1460-2075.1991.tb08059.x. PMC 452772. PMID 1827068.
Marine J, Winoto A (Aug 1991). "The human enhancer-binding protein Gata3 binds to several T-cell receptor regulatory elements". Proceedings of the National Academy of Sciences of the United States of America. 88 (16): 7284–8. Bibcode:1991PNAS...88.7284M. doi:10.1073/pnas.88.16.7284. PMC 52279. PMID 1871134.
Ko LJ, Yamamoto M, Leonard MW, George KM, Ting P, Engel JD (maj 1991). "Murine and human T-lymphocyte GATA-3 factors mediate transcription through a cis-regulatory element within the human T-cell receptor delta gene enhancer". Molecular and Cellular Biology. 11 (5): 2778–84. doi:10.1128/mcb.11.5.2778. PMC 360054. PMID 2017177.
Siegel MD, Zhang DH, Ray P, Ray A (Oct 1995). "Activation of the interleukin-5 promoter by cAMP in murine EL-4 cells requires the GATA-3 and CLE0 elements". The Journal of Biological Chemistry. 270 (41): 24548–55. doi:10.1074/jbc.270.41.24548. PMID 7592673.
Labastie MC, Bories D, Chabret C, Grégoire JM, Chrétien S, Roméo PH (maj 1994). "Structure and expression of the human GATA3 gene". Genomics. 21 (1): 1–6. doi:10.1006/geno.1994.1217. PMID 8088776.
Ono Y, Fukuhara N, Yoshie O (Feb 1997). "Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL". The Journal of Biological Chemistry. 272 (7): 4576–81. doi:10.1074/jbc.272.7.4576. PMID 9020185.
Ono Y, Fukuhara N, Yoshie O (Dec 1998). "TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3". Molecular and Cellular Biology. 18 (12): 6939–50. doi:10.1128/MCB.18.12.6939. PMC 109277. PMID 9819382.
Yang GP, Ross DT, Kuang WW, Brown PO, Weigel RJ (Mar 1999). "Combining SSH and cDNA microarrays for rapid identification of differentially expressed genes". Nucleic Acids Research. 27 (6): 1517–23. doi:10.1093/nar/27.6.1517. PMC 148347. PMID 10037815.
Blumenthal SG, Aichele G, Wirth T, Czernilofsky AP, Nordheim A, Dittmer J (Apr 1999). "Regulation of the human interleukin-5 promoter by Ets transcription factors. Ets1 and Ets2, but not Elf-1, cooperate with GATA3 and HTLV-I Tax1". The Journal of Biological Chemistry. 274 (18): 12910–6. doi:10.1074/jbc.274.18.12910. PMID 10212281.
Van Esch H, Groenen P, Nesbit MA, Schuffenhauer S, Lichtner P, Vanderlinden G, Harding B, Beetz R, Bilous RW, Holdaway I, Shaw NJ, Fryns JP, Van de Ven W, Thakker RV, Devriendt K (Jul 2000). "GATA3 haplo-insufficiency causes human HDR syndrome". Nature. 406 (6794): 419–22. Bibcode:2000Natur.406..419V. doi:10.1038/35019088. PMID 10935639. S2CID 4327212.
Hartley JL, Temple GF, Brasch MA (Nov 2000). "DNA cloning using in vitro site-specific recombination". Genome Research. 10 (11): 1788–95. doi:10.1101/gr.143000. PMC 310948. PMID 11076863.
Muroya K, Hasegawa T, Ito Y, Nagai T, Isotani H, Iwata Y, Yamamoto K, Fujimoto S, Seishu S, Fukushima Y, Hasegawa Y, Ogata T (Jun 2001). "GATA3 abnormalities and the phenotypic spectrum of HDR syndrome". Journal of Medical Genetics. 38 (6): 374–80. doi:10.1136/jmg.38.6.374. PMC 1734904. PMID 11389161.
Crawford SE, Qi C, Misra P, Stellmach V, Rao MS, Engel JD, Zhu Y, Reddy JK (Feb 2002). "Defects of the heart, eye, and megakaryocytes in peroxisome proliferator activator receptor-binding protein (PBP) null embryos implicate GATA family of transcription factors". The Journal of Biological Chemistry. 277 (5): 3585–92. doi:10.1074/jbc.M107995200. PMID 11724781.
Kieffer LJ, Greally JM, Landres I, Nag S, Nakajima Y, Kohwi-Shigematsu T, Kavathas PB (Apr 2002). "Identification of a candidate regulatory region in the human CD8 gene complex by colocalization of DNase I hypersensitive sites and matrix attachment regions which bind SATB1 and GATA-3". Journal of Immunology. 168 (8): 3915–22. doi:10.4049/jimmunol.168.8.3915. PMID 11937547.
Asnagli H, Afkarian M, Murphy KM (maj 2002). "Cutting edge: Identification of an alternative GATA-3 promoter directing tissue-specific gene expression in mouse and human". Journal of Immunology. 168 (9): 4268–71. doi:10.4049/jimmunol.168.9.4268. PMID 11970965.
Steenbergen RD, OudeEngberink VE, Kramer D, Schrijnemakers HF, Verheijen RH, Meijer CJ, Snijders PJ (Jun 2002). "Down-regulation of GATA-3 expression during human papillomavirus-mediated immortalization and cervical carcinogenesis". The American Journal of Pathology. 160 (6): 1945–51. doi:10.1016/S0002-9440(10)61143-1. PMC 1850837. PMID 12057898.
Höfer T, Nathansen H, Löhning M, Radbruch A, Heinrich R (Jul 2002). "GATA-3 transcriptional imprinting in Th2 lymphocytes: a mathematical model". Proceedings of the National Academy of Sciences of the United States of America. 99 (14): 9364–8. Bibcode:2002PNAS...99.9364H. doi:10.1073/pnas.142284699. PMC 123146. PMID 12087127.
Karunaratne A, Hargrave M, Poh A, Yamada T (Sep 2002). "GATA proteins identify a novel ventral interneuron subclass in the developing chick spinal cord". Developmental Biology. 249 (1): 30–43. doi:10.1006/dbio.2002.0754. PMID 12217316.

Vanjski linkovi

GATA3 protein, human na US National Library of Medicine Medical Subject Headings (MeSH)
FactorBook GATA3

[refGRCh38Ensembl-1] GRCh38: Ensembl release 89: ENSG00000107485 - Ensembl, maj 2017

[refGRCm38Ensembl-2] GRCm38: Ensembl release 89: ENSMUSG00000015619 - Ensembl, maj 2017

[3] "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[4] "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[pmid2050118-5] Joulin V, Bories D, Eléouet JF, Labastie MC, Chrétien S, Mattéi MG, Roméo PH (Jul 1991). "A T-cell specific TCR delta DNA binding protein is a member of the human GATA family". The EMBO Journal. 10 (7): 1809–16. doi:10.1002/j.1460-2075.1991.tb07706.x. PMC 452855. PMID 2050118.

[pmid15087456-6] Yamashita M, Ukai-Tadenuma M, Miyamoto T, Sugaya K, Hosokawa H, Hasegawa A, Kimura M, Taniguchi M, DeGregori J, Nakayama T (Jun 2004). "Essential role of GATA3 for the maintenance of type 2 helper T (Th2) cytokine production and chromatin remodeling at the Th2 cytokine gene loci". The Journal of Biological Chemistry. 279 (26): 26983–90. doi:10.1074/jbc.M403688200. PMID 15087456.

[entrez-7] "Entrez Gene: GATA3 GATA binding protein 3".

[8] Zheng, Wei-ping; Flavell, Richard A (maj 1997). "The Transcription Factor GATA-3 Is Necessary and Sufficient for Th2 Cytokine Gene Expression in CD4 T Cells". Cell. 89 (4): 587–596. doi:10.1016/s0092-8674(00)80240-8. PMID 9160750. S2CID 18342599.

[9] Zheng, WP; Flavell, RA (1. 6. 2016). "Pillars Article: The Transcription Factor GATA-3 Is Necessary and Sufficient for Th2 Cytokine Gene Expression in CD4 T Cells. Cell. 1997. 89: 587-596". Journal of Immunology. 196 (11): 4426–35. PMID 27207805.

[pmid29626211-10] Barnes PJ (april 2018). "Targeting cytokines to treat asthma and chronic obstructive pulmonary disease". Nature Reviews. Immunology. 18 (7): 454–466. doi:10.1038/s41577-018-0006-6. PMID 29626211. S2CID 4647119.

[omim.org-11] "OMIM Entry - * 131320 - GATA-BINDING PROTEIN 3; GATA3". omim.org.

[pmid27387476-12] Belge H, Dahan K, Cambier JF, Benoit V, Morelle J, Bloch J, Vanhille P, Pirson Y, Demoulin N (maj 2017). "Clinical and mutational spectrum of hypoparathyroidism, deafness and renal dysplasia syndrome". Nephrology, Dialysis, Transplantation. 32 (5): 830–837. doi:10.1093/ndt/gfw271. PMID 27387476.

[pmid23939152-13] Ordóñez NG (septembar 2013). "Value of GATA3 immunostaining in tumor diagnosis: a review". Advances in Anatomic Pathology. 20 (5): 352–60. doi:10.1097/PAP.0b013e3182a28a68. PMID 23939152. S2CID 8874053.

[UniProt-14] "UniProt, P23771". Pristupljeno 2. 9. 2021.

[15] "Homo sapiens GATA binding protein 3 (GATA3), RefSeqGene on chromosome - Nucleotide - NCBI". www.ncbi.nlm.nih.gov. 21. 5. 2019.

[16] "GATA3-AS1 GATA3 antisense RNA 1 [Homo sapiens (human)] - Gene - NCBI".

[17] "DiGeorge syndrome/velocardiofacial syndrome complex 2 - Conditions - GTR - NCBI". www.ncbi.nlm.nih.gov.

[pmid20425828-18] Lindstrand A, Malmgren H, Verri A, Benetti E, Eriksson M, Nordgren A, Anderlid BM, Golovleva I, Schoumans J, Blennow E (maj 2010). "Molecular and clinical characterization of patients with overlapping 10p deletions". American Journal of Medical Genetics. Part A. 152A (5): 1233–43. doi:10.1002/ajmg.a.33366. PMID 20425828. S2CID 22213304.

[pmid26313026-19] Du F, Yuan P, Wang T, Zhao J, Zhao Z, Luo Y, Xu B (novembar 2015). "The Significance and Therapeutic Potential of GATA3 Expression and Mutation in Breast Cancer: A Systematic Review". Medicinal Research Reviews. 35 (6): 1300–15. doi:10.1002/med.21362. PMID 26313026. S2CID 11668034.

[20] "Homo sapiens GATA binding protein 3 (GATA3), transcript variant 2, mRN - Nucleotide - NCBI". www.ncbi.nlm.nih.gov. 19. 5. 2019.

[ncbi.nlm.nih.gov-21] "trans-acting T-cell-specific transcription factor GATA-3 isoform 1 [Ho - Protein - NCBI". www.ncbi.nlm.nih.gov.

[https://www.omim.org/entry/131320-22] "OMIM Entry - * 131320 - GATA-BINDING PROTEIN 3; GATA3".

[pmid29184556-23] Zhu J (2017). "GATA3 Regulates the Development and Functions of Innate Lymphoid Cell Subsets at Multiple Stages". Frontiers in Immunology. 8: 1571. doi:10.3389/fimmu.2017.01571. PMC 5694433. PMID 29184556.

[24] Yagi R, Zhu J, Paul WE (Jul 2011). "An updated view on transcription factor GATA3-mediated regulation of Th1 and Th2 cell differentiation Z". International Immunology. 23 (7): 415–20. doi:10.1093/intimm/dxr029. PMC 3123974. PMID 21632975.

[pmid17129787-25] Kouros-Mehr H, Slorach EM, Sternlicht MD, Werb Z (Dec 2006). "GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland". Cell. 127 (5): 1041–55. doi:10.1016/j.cell.2006.09.048. PMC 2646406. PMID 17129787.

[pmid26772397-26] Asch-Kendrick R, Cimino-Mathews A (februar 2016). "The role of GATA3 in breast carcinomas: a review". Human Pathology. 48: 37–47. doi:10.1016/j.humpath.2015.09.035. PMID 26772397.

[pmid17349208-27] Ho IC, Pai SY (februar 2007). "GATA-3 - not just for Th2 cells anymore". Cellular & Molecular Immunology. 4 (1): 15–29. PMID 17349208.

[pmid26654192-28] Bachert C, Zhang L, Gevaert P (decembar 2015). "Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis". The Journal of Allergy and Clinical Immunology. 136 (6): 1431–1440. doi:10.1016/j.jaci.2015.10.010. PMID 26654192.

[pmid27910098-29] Garn H, Renz H (januar 2017). "GATA-3-specific DNAzyme - A novel approach for stratified asthma therapy". European Journal of Immunology. 47 (1): 22–30. doi:10.1002/eji.201646450. PMID 27910098.

[pmid23000897-30] Koboldt DC, Fulton RS, McLellan MD (Oct 2012). "Comprehensive molecular portraits of human breast tumours". Nature. 490 (7418): 61–70. Bibcode:2012Natur.490...61T. doi:10.1038/nature11412. PMC 3465532. PMID 23000897.

[pmid18242514-31] Kouros-Mehr H, Bechis SK, Slorach EM, Littlepage LE, Egeblad M, Ewald AJ, Pai SY, Ho IC, Werb Z (Feb 2008). "GATA-3 links tumor differentiation and dissemination in a luminal breast cancer model". Cancer Cell. 13 (2): 141–52. doi:10.1016/j.ccr.2008.01.011. PMC 2262951. PMID 18242514.

[pmid18533032-32] Wilson BJ, Giguère V (2008). "Meta-analysis of human cancer microarrays reveals GATA3 is integral to the estrogen receptor alpha pathway". Molecular Cancer. 7: 49. doi:10.1186/1476-4598-7-49. PMC 2430971. PMID 18533032.

[pmid19483726-33] Dydensborg AB, Rose AA, Wilson BJ, Grote D, Paquet M, Giguère V, Siegel PM, Bouchard M (Jul 2009). "GATA3 inhibits breast cancer growth and pulmonary breast cancer metastasis". Oncogene. 28 (29): 2634–42. doi:10.1038/onc.2009.126. PMID 19483726.

[Sanga_2009-34] Sanga S, Broom BM, Cristini V, Edgerton ME (2009). "Gene expression meta-analysis supports existence of molecular apocrine breast cancer with a role for androgen receptor and implies interactions with ErbB family". BMC Medical Genomics. 2: 59. doi:10.1186/1755-8794-2-59. PMC 2753593. PMID 19747394.

[pmid22706858-35] Liu H, Shi J, Wilkerson ML, Lin F (juli 2012). "Immunohistochemical evaluation of GATA3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas". American Journal of Clinical Pathology. 138 (1): 57–64. doi:10.1309/AJCP5UAFMSA9ZQBZ. PMID 22706858.

[pmid28574279-36] Peng Y, Butt YM, Chen B, Zhang X, Tang P (august 2017). "Update on Immunohistochemical Analysis in Breast Lesions". Archives of Pathology & Laboratory Medicine. 141 (8): 1033–1051. doi:10.5858/arpa.2016-0482-RA. PMID 28574279.

[pmid29614760-37] Inamura K (april 2018). "Bladder Cancer: New Insights into Its Molecular Pathology". Cancers. 10 (4): 100. doi:10.3390/cancers10040100. PMC 5923355. PMID 29614760.

[pmid9819382-38] Ono Y, Fukuhara N, Yoshie O (Dec 1998). "TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3". Molecular and Cellular Biology. 18 (12): 6939–50. doi:10.1128/MCB.18.12.6939. PMC 109277. PMID 9819382.

[pmid9020185-39] Ono Y, Fukuhara N, Yoshie O (Feb 1997). "Transcriptional activity of TAL1 in T cell acute lymphoblastic leukemia (T-ALL) requires RBTN1 or -2 and induces TALLA1, a highly specific tumor marker of T-ALL". The Journal of Biological Chemistry. 272 (7): 4576–81. doi:10.1074/jbc.272.7.4576. PMID 9020185.

[Albergaria_2009-40] Albergaria A, Paredes J, Sousa B, Milanezi F, Carneiro V, Bastos J, Costa S, Vieira D, Lopes N, Lam EW, Lunet N, Schmitt F (2009). "Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumours". Breast Cancer Research. 11 (3): R40. doi:10.1186/bcr2327. PMC 2716509. PMID 19549328.

[5]

[6]

[7]

[1]

[2]

[3]

[4]

[8]

[9]

[10]

[11]

[12]

[13]

[14]

[15]

[16]

[17]

[18]

[19]

[20]

[21]

[22]

[23]

[24]

[25]

[26]

[27]

[28]

[29]

[30]

[31]

[32]

[33]

[34]

[35]

[36]

[37]

[38]

[39]

[40]